TRANSLATIONAL RESEARCH ON CANCER EPIGENETICS
The ERA-NET TRANSCAN-3, in continuity of the preceding ERA-NET TRANSCAN-2, has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The specific challenge is to promote a transnational collaborative approach between scientific teams in demanding areas of translational cancer research while avoiding the duplication of efforts and ensuring a more efficient use of available resources, to produce significant results of higher quality and impact, and share data and infrastructures.
You can consult the requirements of the call and a summary of the eligibility criteria an outline of eligibility criteria. They will be further detailed when the JTC 2023 is published.
The TRANSCAN-3 JTC 2023 will be implemented through a two-stage submission procedure: pre-proposals and full proposals.
The call is planned to be launched on May 9th 2023 with a submission deadline for pre-proposals in July 2023. It is expected that consortia invited to the full-proposal stage will be asked to submit their proposal in December 2023.
For more information, it is recommended to visit the different links available for this purpose.
Funding bodyERA-NET TRANSCAN
Ana Moreno: ambofarull(ELIMINAR)@salud.madrid.org / 91 336 9016
Esther Torrecilla: esther.torrecilla(ELIMINAR)@salud.madrid.org / 91 488 9708